Charite- University Medicine

Berlin 13353

0 studies enrolling now · 9 studies all time

What they study most

Anemia, Hemolytic, Chronic Hepatitis C Infection, Head and Neck Squamous Cell Carcinoma, Hepatitis C, Chronic, Malignant Melanoma, Melanoma, Parkinson´s Disease, Primary Central Nervous System Lymphoma (PCNSL), Pyruvate Kinase Deficiency

Studies at this site

• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
• Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma — Stopped early
• A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) — Completed
• Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors — Stopped early
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• Vaccine Therapy for Patients With Stage III Melanoma — Status unconfirmed
• Vaccine Therapy for Patients With Stage IV Melanoma — Status unconfirmed